HYRESLA
Live / Applied — Second extension granted (statement of use) (as of 24 Nov 2025)
What this means for you
Not registered yet, but its 21 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98190997
- Mark type
- Stylized text
- Filed
- 21 Sept 2023
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of respiratory diseases, eosinophilic diseases, immunoinflammatory diseases, and asthma
Owner
- Areteia Therapeutics, Inc., Chapel Hill, NC, US
- Areteia Therapeutics, Inc., Chapel Hill, NC, US
Prosecution history
- 25 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2025 — SOU EXTENSION 2 GRANTED
- 24 Nov 2025 — SOU EXTENSION 2 FILED
- 24 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2025 — SOU EXTENSION 1 GRANTED
- 01 May 2025 — SOU EXTENSION 1 FILED
- 01 May 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — ASSIGNED TO EXAMINER
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED